Get the app →
BriefTea logoBriefTea

Every story in sixty words

News · 21 June 2026

Puberty blocker trial sets minimum age of 11

Puberty blocker trial sets minimum age of 11

A study evaluating puberty-suppressing medications for children exploring their gender identity will henceforth mandate that participants be no younger than 11. Operations for the Pathways Trial ceased in February 2026 after the Medicines and Healthcare products Regulatory Agency voiced safety worries and recommended a minimum age of 14. Academics at King's College London have consented to implement more robust protections, such as the revised age criteria, with participant enrollment anticipated to commence in August.

By BriefTea Editorial ·

Reported by BBC · How we write briefs

Get the app

More briefs

WorldIran's unseen supreme leader urges Gulf countries to fight a shared enemy BusinessIceland supermarket boss tells the Chancellor to cut business taxes for employers GeneralNigel Farage's £5m donor has major stakes in arms industry PoliticsTreasury officials advise John Healey to tax banks and oil companies more HealthCorrecting hearing loss can cut dementia risk by almost half GeneralNotting Hill Carnival parade begins as Europe's biggest street party Browse all stories →